Bone Tissue Engineering and Stem Cell Differentiation

Bone tissue engineering seeks to restore or replace damaged skeletal structures by combining living cells, biomaterial scaffolds and bioactive factors to recreate a functional bone microenvironment. Central to this endeavour is the directed differentiation of stem cells—particularly mesenchymal stromal cells—into osteoblasts, the bone‐forming cells responsible for extracellular matrix deposition and mineralisation. Advances in scaffold design, ranging from natural polymers to synthetic composites, aim to mimic the hierarchical architecture and mechanical properties of native bone, while providing controlled release of growth factors such as bone morphogenetic proteins and dexamethasone. Bioreactor systems and biophysical stimuli—including mechanical loading and electrical cues—are increasingly employed to enhance cell viability, spatial organisation and osteogenic commitment. Emerging fabrication methods, notably three-dimensional printing and electrospinning, enable precise control over pore geometry and fibre orientation, promoting vascular infiltration and nutrient transport. Despite significant progress, challenges remain in achieving long-term integration, vascularisation and immune compatibility in large defects. Translational studies now emphasise the convergence of material science, developmental biology and clinical orthopaedics to develop off-the-shelf constructs capable of guiding stem cell fate and accelerating in vivo bone regeneration.

Research from Nature Portfolio

No recent Nature Portfolio content available.

Bone Tissue Engineering and Stem Cell Differentiation publication trend

The graph below shows the total number of articles in bone tissue engineering and stem cell differentiation across all publications each year (not limited to Nature Index journals).

Technical terms

Mesenchymal stromal cells: Multipotent progenitors capable of differentiating into osteoblasts, chondrocytes and adipocytes.

Osteogenic differentiation: The process by which precursor cells commit to and develop a bone-forming phenotype.

Scaffold: A three-dimensional biomaterial framework that supports cell attachment, proliferation and tissue development.

Bone morphogenetic protein (BMP): A family of growth factors that regulate bone formation and repair by inducing osteoblast differentiation.

Alkaline phosphatase (ALP): An early marker enzyme of osteoblast activity involved in matrix mineralisation.

References

1. rhBMP-2 induces terminal differentiation of human bone marrow mesenchymal stromal cells only by synergizing with other signals. Stem Cell Research & Therapy (2024).
2. Immediate implantation of ultrafine fiber slow-release system based on cell electrospinning to induce osteogenesis of mesenchymal stem cells. Regenerative Biomaterials (2023).
3. In vitro osteogenesis of hMSCs on collagen membranes embedded within LEGO®-inspired 3D printed PCL constructs for mandibular bone repair. Biofabrication (2024).